J-shaped relationship between cardiovascular risk and efficacy of intensive blood pressure reduction: A post-hoc analysis of the SPRINT trial
Table 5
Serious adverse events, condition of interest and monitored clinical events in participants with a 10-year Framingham cardiovascular risk score> 7.